Oncolytics Biotech Inc. (ONCY) Ownership

NASDAQ: ONCYTop holders, insider trades and short interest.

ONCY ownership summary

as of October 18, 2026
Institutions
9.0%
of shares outstanding
Insiders
1.66%
of shares outstanding
Shares outstanding
131.1M
Float
125.1M
shares available to trade
Short interest
5.75%
7.4M shares short
Days to cover
6.69
short interest down 14.7% vs prior month
  • Institutions 9.03%
  • Insiders 1.66%
  • Other investors 89.31%

ONCY top institutional holders

20 largest
Oncolytics Biotech Inc. top institutional holders
#Holder% of sharesSharesValueChangeReported
1Marshall Wace Asset Management Ltd0.57%745K$372,675−114,481 (−13.3%)June 30, 2026
2Sandbox Financial Partners, LLC0.31%400K$200,000+400,000 (0.0%)March 31, 2026
3XTX Topco Ltd0.20%261K$130,452+151,145 (+137.7%)June 30, 2026
4SEEDS INVESTOR LLC0.20%258K$129,153—June 30, 2026
5International Assets Investment Management, LLC0.15%201K$100,630+201,260 (0.0%)June 30, 2026
6Connective Capital Management LLC0.14%186K$92,856+185,712 (0.0%)June 30, 2026
7The Goldman Sachs Group Inc0.13%170K$84,949+169,898 (0.0%)June 30, 2026
8Tocqueville Asset Management L.P.0.11%147K$73,500−2,000 (−1.3%)June 30, 2026
9Everhart Financial Group, Inc.0.11%141K$70,450+2,738 (+2.0%)June 30, 2026
10Susquehanna International Group, LLP0.10%134K$67,064+92,806 (+224.6%)June 30, 2026
11PFG Investments, LLC0.10%128K$64,150+75,400 (+142.5%)June 30, 2026
12HRT FINANCIAL LLC0.10%126K$63,162+103,069 (+443.2%)June 30, 2026
13Amvescap Plc.0.08%101K$50,598+101,195 (0.0%)June 30, 2026
14Doliver Capital Advisors, Inc.0.08%100K$50,000—June 30, 2026
15LPL Financial Corp0.06%80K$40,158+1,415 (+1.8%)June 30, 2026
16Franklin Templeton Inc0.06%80K$39,921+10,000 (+14.3%)June 30, 2026
17CIBC World Markets Inc.0.05%69K$34,652+9,000 (+14.9%)June 30, 2026
18Geode Capital Management, LLC0.05%67K$33,470—June 30, 2026
19Renaissance Technologies Corp0.05%62K$31,005−653,828 (−91.3%)June 30, 2026
20Royal Bank of Canada0.04%57K$28,706+57,411 (0.0%)June 30, 2026

Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 14 holders added 1.6M shares and 3 cut 770K.

ONCY top mutual fund and ETF holders

2 largest
Oncolytics Biotech Inc. top fund holders
#Holder% of sharesSharesValueChangeReported
1Invesco NASDAQ Future Gen 200 ETF0.11%142K$71,121—September 30, 2026
2Victory Extended Market Index0.01%14K$6,753+13,506 (0.0%)June 30, 2026

Funds report holdings monthly or quarterly; dates differ by fund.

ONCY insider transactions

latest 14
Oncolytics Biotech Inc. insider transactions
DateNameTransactionPriceSharesValue
2026-03-12Jared KellyBuy$0.965,050$4,848
2026-03-11James T ParsonsBuy$1.0310,000$10,300
2026-02-12Allison HagermanBuy$0.8310,000$8,300
2026-02-12Bernd R SeizingerBuy$0.8540,000$34,000
2026-02-12Deborah Margaret BrownBuy$0.8525,000$21,250
2026-02-12Jared KellyBuy$0.8429,500$24,780
2026-02-12Kirk LookBuy$0.8412,000$10,080
2026-02-12Patricia S AndrewsBuy$0.8635,400$30,444
2026-02-12Thomas Charles HeinemanBuy$0.8312,132$10,070
2026-02-12Wayne PisanoBuy$0.8430,000$25,200
2026-02-11Andrew AromandoBuy$0.8629,600$25,456
2026-02-11Bernd R SeizingerBuy$0.8360,000$49,800
2026-02-11Jared KellyBuy$0.845,600$4,704
2026-01-16Bernd R SeizingerBuy$1.04100,000$104,000

Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.

ONCY shares outstanding

Shares outstanding

Year-end shares outstanding, adjusted for splits.

Who owns ONCY

Institutional investors own 9.0% of Oncolytics Biotech's shares and insiders 1.66%. The largest holder is Marshall Wace Asset Management Ltd with 0.57% of the shares (745K), as of June 30, 2026. Among the top 20 institutions, 14 added shares and 3 reduced their stake in the latest filings. Short interest is 5.75% of the float, or 6.69 days of average trading volume. The share count rose 930.8% since 2014.

Related: ONCY analyst forecast. See the ONCY stock overview for the latest quote and news.

ONCY ownership FAQ

Who owns the most Oncolytics Biotech stock?

The largest shareholders of Oncolytics Biotech are Marshall Wace Asset Management Ltd (0.57%), Sandbox Financial Partners, LLC (0.31%), XTX Topco Ltd (0.20%), SEEDS INVESTOR LLC (0.20%), International Assets Investment Management, LLC (0.15%).

What percentage of Oncolytics Biotech is owned by institutions?

Institutions hold 9.0% of Oncolytics Biotech's shares outstanding; insiders hold 1.66%.

Which funds own Oncolytics Biotech?

The largest fund holders of Oncolytics Biotech are Invesco NASDAQ Future Gen 200 ETF (0.11%), Victory Extended Market Index (0.01%).

What is Oncolytics Biotech's short interest?

7.4M shares of Oncolytics Biotech were sold short, 5.75% of the float; at the average daily volume it would take 6.69 days to cover.

Are insiders buying or selling Oncolytics Biotech?

Of the latest 14 reported insider transactions in Oncolytics Biotech (since January 16, 2026), 14 were purchases and 0 were sales.

How many shares of Oncolytics Biotech are outstanding?

Oncolytics Biotech has 131.1M shares outstanding, of which 125.1M are in the public float.

Biotechnology: ownership